• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
CHEN Ziyi,HUANG Xiaoyang,ZENG Zhenhua,TANG Rihong,WU Weihua.The therapeutic effect of sinomenine on pulmonary arterial hypertension in rats and analysis of its key signaling pathways[J].Journal Of Pharmaceutical Research,2026,45(7):729-733,751[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 954times   Download 567次 QR Code for this article
Scan with your phone!
青藤碱对大鼠肺动脉高压的治疗作用及其关键信号通路分析
陈子怡1,黄小阳2,曾振华2,唐日红2,吴卫华1,2
Font:Larger+|Default|Smaller-
(1.徐州医科大学药学院,江苏 徐州 221004;2.湖南医药学院药学院,湖南 怀化 418000)
摘要:
目的 探讨青藤碱(SIN)对野百合碱(MCT)诱导的大鼠肺动脉高压(PAH)的防治作用及潜在调控信号通路。方法 通过MCT诱导构建大鼠PAH模型;右心导管法检测大鼠右心室压;利用高通量测序技术分析大鼠肺组织基因表达谱,并利用富集分析筛选SIN改善MCT诱导大鼠PAH的关键信号通路,最后利用qRT-PCR检测通路中核心基因的表达。结果 SIN可以抑制MCT诱导的大鼠右心室压的升高和肺动脉血管的增厚,通过对肺组织转录组数据的分析和肺动脉qRT-PCR检测发现,SIN可能通过抑制胞外基质-受体相互作用信号通路改善MCT诱导的大鼠PAH。结论 SIN可能通过抑制胞外基质-受体相互作用信号通路改善MCT诱导的大鼠PAH。
关键词:  青藤碱  肺动脉高压  胞外基质  信号通路
DOI:10.13506/j.cnki.jpr.2026.07.002
基金项目:湖南省自然科学基金区域联合项目(No.2025JJ70468);湖南省教育厅科学研究项目(No.23B1052、23A0720)
Received Date:October 09, 2025   Revision Date:February 13, 2026   Publication Date:July 31, 2026
The therapeutic effect of sinomenine on pulmonary arterial hypertension in rats and analysis of its key signaling pathways
CHEN Ziyi1,HUANG Xiaoyang2,ZENG Zhenhua2,TANG Rihong2,WU Weihua1,2
(1.School of Pharmacy,Xuzhou Medical University,Xuzhou 221004,China; 2. School of Pharmaceutical Sciences, Hunan University of Medicine, Huaihua 418000,China)
Abstract:
Objective  This study aimed to explore the preventive and therapeutic effects of sinomenine (SIN) on monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH) in rats, as well as its potential regulatory signaling pathways.Methods  A rat model of PAH was established via MCT induction. Right heart catheterization was performed to measure the right ventricular systolic pressure (RVSP) in rats. High-throughput sequencing technology was used to analyze the gene expression profile of rat lung tissues, and enrichment analysis was employed to screen the key signaling pathways through which SIN ameliorates MCT-induced PAH in rats. Finally, quantitative real-time polymerase chain reaction (qRT-PCR) was utilized to detect the expression of core genes in the identified pathways.Results  SIN significantly inhibited the MCT-induced increase in RVSP and thickness of pulmonary arterial vessels in rats. Analysis of lung tissue transcriptome data and detection of pulmonary arterial vascular genes revealed that SIN might ameliorate MCT-induced PAH in rats by inhibiting the extracellular matrix (ECM)-receptor interaction signaling pathway.Conclusion  SIN may ameliorate MCT-induced PAH in rats by inhibiting the ECM-receptor interaction signaling pathway.
Key words:  Sinomenine  Pulmonary arterial hypertension  Extracellular matrix  Signaling pathway
Today's Visits:465    Total Visits:2383161
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.